Aktiesnakken — Juni 2010
-
Sevan er også et superkøb
-
Har du tjekket den hegu
-
multipronged approach to generating more revenue streams
-
har i hørt lignende vås før?
-
de store kører rundt med de små
-
jeg tror genmab er solgt i år
-
om 2måneder har vi en transparent strategi
-
GSK styrer det show
-
51,65
-
nu kan jeg jo genkøbe i de forbudte
-
jeg er slet ikke så negativ
-
tak til aka for referat. Men puha der er stadig mange udestående spørgsmål....
-
de institutionelle har intet i genmab
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind